<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03502369</url>
  </required_header>
  <id_info>
    <org_study_id>050108004</org_study_id>
    <nct_id>NCT03502369</nct_id>
  </id_info>
  <brief_title>Ultrasound Guided Quadratus Lumborum Block for Post Operative Analgesia After Hip Arthroplasty</brief_title>
  <official_title>Randomized, Controlled, Double Blind Trial of Ultrasound Guided Quadratus Lumborum Block for Post Operative Analgesia After Hip Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alexandria University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alexandria University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study evaluates the effectiveness of anterior quadratus lumborum block for post operative
      analgesia after hip arthroplasty. Half of the participants will receive ultrasound guided
      anterior quadratus lumborum block using 30ml bupivacaine 0.375%, while the other half will
      not receive the block ( control group).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sensory innervation of the hip region involves branches of the lumbar plexus and sacral
      plexus. Effective post operative analgesia can be approached by blocking the lumbar plexus at
      the level of the quadratus lumborum muscle. Quadratus lumborum block has several approach
      methods (anterior, lateral, posterior, and intramuscular). Anterior quadratus lumborum block
      also known as transmuscular QL block or QL3, the local anaesthetic (30ml of bupivacaine
      0.375%) is injected between the psoas major muscle (PM) and the quadratus lumborum muscle
      (QL). Therefore, the anterior quadratus lumborum block may generate analgesia from T10 to L4
      covering the sensory innervation of the hip region.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">September 2018</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Adult 90 orthopaedic patient ASA physical status |-||| will be randomly allocated in two groups each one 45 patients, one group will receive the anterior quadratus lumborum block and the other group will not receive the block.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain intensity assessment</measure>
    <time_frame>every hour for the first 4 post operative hours and then every 4 hours for the rest of the 24 post operative hours.</time_frame>
    <description>Patients will be trained to use visual analogue scale which consists of 10cm line, 0 cm equivalent to no pain and 10 cm denoting the worst imaginable pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total amount of post operative morphine (mg).</measure>
    <time_frame>any time in the first 24 post operative hours.</time_frame>
    <description>Total amount of post operative morphine (mg) used as rescue analgesia and the first time of its request.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Patient satisfaction.</measure>
    <time_frame>every hour in the first 4 post operative hours and then every 4 hours for the rest of the 24 post operative hours.</time_frame>
    <description>Patient satisfaction with pain control will be assessed on a four point scale 1.Excellent 2.Good 3.fair 4.poor</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>QL group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Anterior Quadratus lumborum block will be done for all patients of these group. Local anaesthetic (30ml of bupivacaine) will be injected in fascial plane between the quadratus lumborum muscle and Psoas major muscle by using the ultrasound.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients of these group will be the control group. The will receive acetaminophen 1g every 8h, ketorolac 30mg ever 12h and as required morphine 2mg for post operative analgesia after hip arthroplasty.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Anterior Quadratus lamborum block</intervention_name>
    <description>Local anaesthetic will be injected in the fascial plane between psoas major muscle and quadratus lumborum muscle.</description>
    <arm_group_label>QL group</arm_group_label>
    <other_name>Transmuscular QL block</other_name>
    <other_name>QL3</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American society of anesthesiologists physical status |-||| , scheduled to undergo
             unilateral hip replacement via lateral approach.

        Exclusion Criteria:

          -  patient refusal.

          -  History of neurological/neuromuscular, psychiatric, dementia preventing proper
             comprehension.

          -  coagulation disorders.

          -  History of allergy to the study medication.

          -  Infection overlying the injection site.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Alexandria faculty of medicine</name>
      <address>
        <city>Alexandria</city>
        <zip>21519</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>moutaz Ghandour, professor</last_name>
      <phone>01003363712</phone>
      <email>moutaz.ghandour@alexmed.edu.eg</email>
    </contact>
    <investigator>
      <last_name>Abdullah Gaber, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Ueshima H, Otake H, Lin JA. Ultrasound-Guided Quadratus Lumborum Block: An Updated Review of Anatomy and Techniques. Biomed Res Int. 2017;2017:2752876. doi: 10.1155/2017/2752876. Epub 2017 Jan 3. Review.</citation>
    <PMID>28154824</PMID>
  </reference>
  <results_reference>
    <citation>Sauter AR, Ullensvang K, Niemi G, Lorentzen HT, Bendtsen TF, BÃ¸rglum J, Pripp AH, Romundstad L. The Shamrock lumbar plexus block: A dose-finding study. Eur J Anaesthesiol. 2015 Nov;32(11):764-70. doi: 10.1097/EJA.0000000000000265.</citation>
    <PMID>26426575</PMID>
  </results_reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 11, 2018</study_first_submitted>
  <study_first_submitted_qc>April 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 18, 2018</study_first_posted>
  <last_update_submitted>April 17, 2018</last_update_submitted>
  <last_update_submitted_qc>April 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Alexandria University</investigator_affiliation>
    <investigator_full_name>Abdullah Gaber</investigator_full_name>
    <investigator_title>Registeral</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>De identified individual participant data for all primary and secondary outcome measures will be made available.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

